FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2579782479> ?p ?o ?g. }

• W2579782479 endingPage "635" @default.
• W2579782479 startingPage "625" @default.
• W2579782479 abstract "Little is known about the onset of action after intravenous or oral administration of acetylsalicylic acid (ASA) in patients with acute coronary syndromes (ACS). The aim of the study was to compare intravenous 250 or 500 mg acetylsalicylic acid (ASA) with oral 300 mg in ASA naïve patients with ACS concerning the onset of antiplatelet effects measured by time dependent thromboxane inhibition. A total of 270 patients with ACS < 24 hours were randomised into one of three treatment arms comprising administration of a single dose of ASA as soon as possible after admission. The primary endpoint was platelet inhibition assessed by measurement of arachidonic acid (AA)-induced platelet thromboxane release (TXB2) 5 minutes (min) after study drug administration. Both 250 mg and 500 mg ASA i. v. inhibited TXB2 formation nearly completely (geometric means: from 581.7 and 573.9 ng/ml at baseline to 3.9 and 3.1 ng/ml at 5 min, respectively) compared to 300 mg oral ASA (geometric means: from 652.0 to 223.7 ng/ml) (p-value, ANCOVA: < 0.0001). Similar results were obtained for inhibition of AA-induced platelet aggregation (Multiplate ASPItest; from means 86.41 and 85.72 U to 23.04 and 20.57 U at 5 min, respectively) compared to 300 mg oral ASA from mean 87.18 to 75.56 U (p-value, ANCOVA: <0.0001). The rate of bleedings was low and comparable between the groups. In summary, the administration of a single dose of 250 or 500 mg ASA IV compared to 300 mg orally is associated with a faster and more complete inhibition of thromboxane generation and platelet aggregation. Bleeding complications were comparable between the groups." @default.
• W2579782479 created "2017-01-26" @default.
• W2579782479 creator A5019007539 @default.
• W2579782479 creator A5035254382 @default.
• W2579782479 creator A5037605303 @default.
• W2579782479 creator A5055918346 @default.
• W2579782479 creator A5057727974 @default.
• W2579782479 creator A5061869826 @default.
• W2579782479 creator A5068846586 @default.
• W2579782479 creator A5071887304 @default.
• W2579782479 creator A5078366960 @default.
• W2579782479 creator A5085798844 @default.
• W2579782479 date "2017-01-01" @default.
• W2579782479 modified "2023-09-23" @default.
• W2579782479 title "Prospective, randomised trial of the time dependent antiplatelet effects of 500 mg and 250 mg acetylsalicylic acid i. v. and 300 mg p. o. in ACS (ACUTE)" @default.
• W2579782479 cites W132915687 @default.
• W2579782479 cites W196456583 @default.
• W2579782479 cites W1987786332 @default.
• W2579782479 cites W1991804162 @default.
• W2579782479 cites W2004590941 @default.
• W2579782479 cites W2018805161 @default.
• W2579782479 cites W2024352468 @default.
• W2579782479 cites W2028882499 @default.
• W2579782479 cites W2033758422 @default.
• W2579782479 cites W2035542600 @default.
• W2579782479 cites W2038553766 @default.
• W2579782479 cites W2058651927 @default.
• W2579782479 cites W2093279552 @default.
• W2579782479 cites W2112380741 @default.
• W2579782479 cites W2122485640 @default.
• W2579782479 cites W2129827845 @default.
• W2579782479 cites W2144206796 @default.
• W2579782479 cites W2148352532 @default.
• W2579782479 cites W2148819716 @default.
• W2579782479 cites W2162205054 @default.
• W2579782479 cites W2316166446 @default.
• W2579782479 cites W2409139602 @default.
• W2579782479 cites W3030817736 @default.
• W2579782479 cites W4235459854 @default.
• W2579782479 cites W62025283 @default.
• W2579782479 doi "https://doi.org/10.1160/th16-08-0650" @default.
• W2579782479 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28102427" @default.
• W2579782479 hasPublicationYear "2017" @default.
• W2579782479 type Work @default.
• W2579782479 sameAs 2579782479 @default.
• W2579782479 citedByCount "30" @default.
• W2579782479 countsByYear W25797824792017 @default.
• W2579782479 countsByYear W25797824792018 @default.
• W2579782479 countsByYear W25797824792020 @default.
• W2579782479 countsByYear W25797824792021 @default.
• W2579782479 countsByYear W25797824792022 @default.
• W2579782479 countsByYear W25797824792023 @default.
• W2579782479 crossrefType "journal-article" @default.
• W2579782479 hasAuthorship W2579782479A5019007539 @default.
• W2579782479 hasAuthorship W2579782479A5035254382 @default.
• W2579782479 hasAuthorship W2579782479A5037605303 @default.
• W2579782479 hasAuthorship W2579782479A5055918346 @default.
• W2579782479 hasAuthorship W2579782479A5057727974 @default.
• W2579782479 hasAuthorship W2579782479A5061869826 @default.
• W2579782479 hasAuthorship W2579782479A5068846586 @default.
• W2579782479 hasAuthorship W2579782479A5071887304 @default.
• W2579782479 hasAuthorship W2579782479A5078366960 @default.
• W2579782479 hasAuthorship W2579782479A5085798844 @default.
• W2579782479 hasConcept C126322002 @default.
• W2579782479 hasConcept C181199279 @default.
• W2579782479 hasConcept C185592680 @default.
• W2579782479 hasConcept C2776785769 @default.
• W2579782479 hasConcept C2777056448 @default.
• W2579782479 hasConcept C2777628954 @default.
• W2579782479 hasConcept C2778078955 @default.
• W2579782479 hasConcept C2781024287 @default.
• W2579782479 hasConcept C2781080829 @default.
• W2579782479 hasConcept C42219234 @default.
• W2579782479 hasConcept C55493867 @default.
• W2579782479 hasConcept C71924100 @default.
• W2579782479 hasConcept C89560881 @default.
• W2579782479 hasConcept C90924648 @default.
• W2579782479 hasConcept C98274493 @default.
• W2579782479 hasConceptScore W2579782479C126322002 @default.
• W2579782479 hasConceptScore W2579782479C181199279 @default.
• W2579782479 hasConceptScore W2579782479C185592680 @default.
• W2579782479 hasConceptScore W2579782479C2776785769 @default.
• W2579782479 hasConceptScore W2579782479C2777056448 @default.
• W2579782479 hasConceptScore W2579782479C2777628954 @default.
• W2579782479 hasConceptScore W2579782479C2778078955 @default.
• W2579782479 hasConceptScore W2579782479C2781024287 @default.
• W2579782479 hasConceptScore W2579782479C2781080829 @default.
• W2579782479 hasConceptScore W2579782479C42219234 @default.
• W2579782479 hasConceptScore W2579782479C55493867 @default.
• W2579782479 hasConceptScore W2579782479C71924100 @default.
• W2579782479 hasConceptScore W2579782479C89560881 @default.
• W2579782479 hasConceptScore W2579782479C90924648 @default.
• W2579782479 hasConceptScore W2579782479C98274493 @default.
• W2579782479 hasIssue "03" @default.
• W2579782479 hasLocation W25797824791 @default.
• W2579782479 hasLocation W25797824792 @default.
• W2579782479 hasOpenAccess W2579782479 @default.
• W2579782479 hasPrimaryLocation W25797824791 @default.

• next